SAN DIEGO--(BUSINESS WIRE)--National Resilience, Inc. (Resilience), a technology focused manufacturing company dedicated to broadening access to complex medicines, today announced the acquisition of SwiftScale Biologics, a San Leandro, California-based company developing cell-free protein synthesis (CFPS) technology.
Click here to read the full press release from Business Wire.
Long-term partnership to be established between Resilience and AstraZeneca for the biomanufacturing of established and emerging modalities. West...
SAN DIEGO, CA, September 30, 2024 – National Resilience, Inc. (Resilience), a technology-focused biomanufacturing company dedicated to broadening...
SAN DIEGO & BOSTON & CAMBRIDGE, Mass.--(BUSINESS WIRE)--National Resilience, Inc. (Resilience) and bluebird bio, Inc. (NASDAQ: BLUE), today announced...